Effects of blood purification combined with ulinastatin on HMGB1, IL⁃6, IL⁃17, and IL⁃33 in peripheral blood of patients with sepsis complicated with acute lung injury

LI Shoupeng; MENG Lei

doi:10.14188/j.1671-8852.2023.0030

您当前的位置：

首页 >

文章列表页 >

Effects of blood purification combined with ulinastatin on HMGB1, IL⁃6, IL⁃17, and IL⁃33 in peripheral blood of patients with sepsis complicated with acute lung injury

更新时间：2026-11-05

- Effects of blood purification combined with ulinastatin on HMGB1, IL⁃6, IL⁃17, and IL⁃33 in peripheral blood of patients with sepsis complicated with acute lung injury
- Medical Journal of Wuhan University Vol. 46, Issue 4, Pages: 474-479(2025)
- 作者机构：
  
  1.武汉市第三医院/武汉大学附属同仁医院急诊医学科湖北武汉 430060
  2.武汉同济航天城医院重症医学科湖北武汉 430056
- 作者简介：
- 基金信息：
- DOI：10.14188/j.1671-8852.2023.0030
  CLC： R432.6
- Received：16 January 2023，
  
  Published：25 April 2025
- 稿件说明：
移动端阅览
李寿彭,孟磊.血液净化联合乌司他丁治疗对脓毒症合并急性肺损伤患者外周血HMGB1、IL⁃6、IL⁃17和IL⁃33的影响[J].武汉大学学报（医学版）,2025,46(04):474-479.

LI Shoupeng,MENG Lei.Effects of blood purification combined with ulinastatin on HMGB1, IL⁃6, IL⁃17, and IL⁃33 in peripheral blood of patients with sepsis complicated with acute lung injury[J].Medical Journal of Wuhan University,2025,46(04):474-479.
李寿彭,孟磊.血液净化联合乌司他丁治疗对脓毒症合并急性肺损伤患者外周血HMGB1、IL⁃6、IL⁃17和IL⁃33的影响[J].武汉大学学报（医学版）,2025,46(04):474-479. DOI： 10.14188/j.1671-8852.2023.0030.

LI Shoupeng,MENG Lei.Effects of blood purification combined with ulinastatin on HMGB1, IL⁃6, IL⁃17, and IL⁃33 in peripheral blood of patients with sepsis complicated with acute lung injury[J].Medical Journal of Wuhan University,2025,46(04):474-479. DOI： 10.14188/j.1671-8852.2023.0030.

摘要

目的

探讨应用血液净化联合乌司他丁对脓毒症合并急性肺损伤（ALI）的效果。

方法

选取武汉市第三医院/武汉大学附属同仁医院重症医学科2020年3月至2021年8月收治的84例脓毒症合并ALI者为研究对象，按治疗方法不同，分成观察组（

=42）、对照组（

=42）。两组患者均给予常规治疗，对照组在此基础上采取持续血液净化治疗，而观察组则在对照组基础上同时给予乌司他丁，比较各组患者治疗效果、治疗前与治疗10 d的血清炎症指标[高迁移率族蛋白B1（HMGB1）、白细胞介素⁃6（IL⁃6）、白细胞介素⁃17（IL⁃17）、白细胞介素⁃33（IL⁃33）

]

、血气指标[血氧饱和度（SaO

）、动脉血氧分压（PaO

）、动脉血二氧化碳分压（PaCO

）、氧合指数（OI）

]

、肺功能指标[第1秒用力呼气容积（FEV

）、用力肺活量（FVC）、FEV

/FVC

]

水平；治疗前后采取急性生理功能和慢性健康状况评分系统Ⅱ(APACHE Ⅱ)、序贯器官衰竭评分（SOFA）评价患者病情严重程度。

结果

总有效率观察组高，同对照组差异有统计学意义（

0.05）。两组在治疗后10 d的HMGB1、IL⁃6、IL⁃17、IL⁃33、PaCO

、APACHE Ⅱ评分、SOFA评分降低，且观察组指标比对照组低（

0.05）；而两组SaO

、PaO

、FEV

、FVC、FEV

/FVC指标较治疗前提高，且观察组指标高于对照组（

0.05）。

结论

应用血液净化联合乌司他丁治疗脓毒症合并ALI患者效果满意，有效改善炎症指标、血气指标及肺功能指标，减轻患者病情严重程度，值得推广。

Abstract

Objective

To investigate the effect of blood purification combined with ulinastatin on sepsis complicated with acute lung injury (ALI).

Methods

A total of

84 patients with sepsis complicated with ALI were treated from March 2020 to August 2021 at Wuhan Third Hospital and Tongren Hospital of Wuhan University. These patients were included in this study and divided into an observation group (

=42) and a control group (

=42) based on different treatment methods. Patients in both groups were given conventional treatment. The control group received continuous blood purification treatment in addition to the conventional treatment

while the observation group received ulinastatin treatment in addition to the control group's treatment.The therapeutic effect

serum inflammation indexes (high mobility group protein B1 (HMGB1)

interleukin⁃6 (IL⁃6)

interleukin⁃17 (IL⁃17)

and interleukin⁃33 (IL⁃33))

blood gas indexes (blood oxygen saturation (SaO

)

arterial partial pressure of oxygen (PaO

)

arterial partial pressure of carbon dioxide (PaCO

)

and oxygenation index (OI))

and pulmonary function indicators (forced expiratory volume in the first second (FEV

)

forced vital capacity (FVC)

and FEV

/FVC)were compared. Acute Physiological Function and Chronic Health Status Score System Ⅱ(APACHE Ⅱ) and Sequential Organ Failure Score (SOFA) were used to evaluate the severity of the patients before and after treatment.

Results

The overall effective rate of the observation group was higher than that of the control group (

0.05). After 10 days of treatment

HMGB1

IL⁃6

IL⁃17

IL⁃33

PaCO

APACHE Ⅱ scores

and SOFA scores in both groups were significantly reduced. These indicators were significantly lower in the observation group than in the control group (

0.05). In contrast

the indexes of SaO

PaO

FEV

FVC and FEV

/FVC in both groups were significantly increased after 10 days of treatment. These indexes were significantly higher in the observation group tha

n in the control group (

0.05).

Conclusion

Blood purification combined with ulinastatin is effective in the treatment of sepsis and ALI patients

especially in improving inflammation indexes

blood gas indexes and lung function indexes

and reducing the severity of patients' disease

thereby deserving further application.

关键词

Keywords

references

李乐辉 , 杨远征 , 林润 , 等 . 不同剂量血必净注射液联合乌司他丁注射液治疗脓毒症合并急性肺损伤的临床观察 [J ] . 中国药房 , 2020 , 31 ( 13 ): 51617 ⁃ 51621 .

LI L H , YANG Y Z , LIN R , et al . Clinical observation of different doses of Xuebijing Injection combined with ulinastatin injection in the treatment of sepsis complicated with acute lung injury [J ] . Chinese Pharmacy , 2020 , 31 ( 13 ): 51617 ⁃ 51621 .

LU Q , ZHANG D , LIU H , et al . miR⁃942⁃5p prevents sepsis⁃induced acute lung injury via targeting TRIM37 [J ] . Int J Exp Pathol , 2021 , 102 ( 4/5 ): 192 ⁃ 199 .

徐国平 , 付翃 . 乌司他丁联合连续性血液净化治疗老年脓毒血症休克的效果 [J ] . 中国老年学杂志 , 2021 , 41 ( 1 ): 88 ⁃ 91 .

XU G P , FU H . Effect of ulinastatin combined with continuous blood purification on senile septic shock [J ] . Chinese Journal of Gerontology , 2021 , 41 ( 1 ): 88 ⁃ 91 .

边伟帅 , 陈炜 , 赵磊 , 等 . 乌司他丁联合维生素E对大鼠脓毒症急性呼吸窘迫综合征模型炎症反应的抑制作用研究 [J ] . 中国临床药理学杂志 , 2020 , 36 ( 11 ): 1496 ⁃ 1498,1510 .

BIAN W S , CHEN W , ZHAO L , et al . Inhibitory effect of ulinastatin combined with vitamin E on early inflammatory response in acute respiratory distress syndrome model in rats [J ] . Chin J Clin Pharmacol , 2020 , 36 ( 11 ): 1496 ⁃ 1498,1510 .

王丽辉 , 申亚晖 , 郭艳青 , 等 . 双歧杆菌联合乌司他丁对脓毒症模型大鼠免疫功能的影响 [J ] . 中国免疫学杂志 , 2018 , 34 ( 1 ): 95 ⁃ 98 .

WANG L H , SHEN Y H , GUO Y Q , et al . Effects of bifidobacterium combined with ulinastatin on immune function of CLP rats [J ] . Chinese Journal of Immunology , 2018 , 34 ( 1 ): 95 ⁃ 98 .

中国医师协会急诊医师分会 , 中国研究型医院学会休克与脓毒症专业委员会 . 中国脓毒症/脓毒性休克急诊治疗指南(2018) [J ] . 临床医学研究与实践 , 2018 , 3 ( 29 ): 207 .

Emergency Physician Branch of Chinese Medical Doctor Association , Shock and Sepsis Professional Committee of the Chinese Society of Research Hospitals . Guidelines for emergency treatment of sepsis/septic shock in China (2018) [J ] . Clinical Medicine Research and Practice , 2018 , 3 ( 29 ): 207 .

刘源 , 梅建强 , 施保柱 , 等 . 血必净注射液联合乌司他丁对脓毒症合并ARDS患者肺血管通透性的临床疗效研究 [J ] . 中国中西医结合急救杂志 , 2021 , 28 ( 4 ): 385 ⁃ 389 .

LIU Y , MEI J Q , SHI B Z , et al . Clinical study of effect of Xuebijing injection combined with Ulinastatin on sepsis acute respiratory distress syndrome patients' pulmonary vascular permeability [J ] . Chin J TCM WM Crit Care , 2021 , 28 ( 4 ): 385 ⁃ 389 .

KITZMILLER L , LEDFORD J R , HAKE P W , et al . Activation of AMP⁃activated protein kinase by A769662 ameliorates sepsis⁃induced acute lung injury in adult mice [J ] . Shock , 2019 , 52 ( 5 ): 540 ⁃ 549 .

李永宁 , 王磊 , 陈俊杰 , 等 . 乌司他丁对脓毒症大鼠肺损伤抑炎及抗凋亡信号机制的研究 [J ] . 中国急救医学 , 2018 , 38 ( 7 ): 626 ⁃ 630, I 0004 .

LI Y N , WANG L , CHEN J J , et al . The protective effect and ameliorating cell apoptosis of ulinastatin on lung tissue in septic rats [J ] . Chin J Crit Care , 2018 , 38 ( 7 ): 626 ⁃ 630, I 0004 .

张凯凯 , 于学忠 , 梁显泉 , 等 . 乌司他丁对脓毒症伴多器官衰竭患者血清降钙素原C反应蛋白及免疫功能的影响 [J ] . 中国急救医学 , 2018 , 38 ( 4 ): 328 ⁃ 331 .

ZHANG K K , YU X Z , LIANG X Q , et al . Effects of ulinastatin on serum procalcitonin, C⁃reactive protein and immune function in patients with sepsis complicated with multiple organ failure [J ] . Chin J Crit Care , 2018 , 38 ( 4 ): 328 ⁃ 331 .

白士先 , 李素华 , 庄文欣 . 不同剂量乌司他丁对脓毒症大鼠炎症因子及细胞免疫的调节作用 [J ] . 中国急救医学 , 2021 , 41 ( 9 ): 784 ⁃ 789 .

BAI S X , LI S H , ZHUANG W X . Effects of different doses of ulinastatin on inflammatory factors and cellular immunity in septic rats [J ] . Chin J Crit Care , 2021 , 41 ( 9 ): 784 ⁃ 789 .

DOS SANTOS C C , VASWANI C M , MEI S H J , et al . Reply: Mesenchymal stromal (stem) cell therapy modulates miR⁃193b⁃5p expression to attenuate sepsis⁃induced acute lung injury [J ] . Eur Respir J , 2023 , 61 ( 2 ): 2200886 ⁃ 2200886 .

陈玉红 , 张坤 , 胡振杰 . 不同剂量乌司他丁对脓毒症心肌功能障碍小鼠的保护作用及其机制研究 [J ] . 中国急救医学 , 2019 , 39 ( 11 ): 1089 ⁃ 1094 .

CHEN Y H , ZHANG K , HU Z J . The cardiac protective effects of ulinastatin in different dose for sepsis⁃induced myocardial dysfunction mice [J ] . Chin J Crit Care , 2019 , 39 ( 11 ): 1089 ⁃ 1094 .

陶杨 , 肖玲 , 黄健 , 等 . 乌司他丁通过miR⁃21/p38MAPK通路对脓毒症保护作用的研究 [J ] . 中华急诊医学杂志 , 2018 , 27 ( 11 ): 1242 ⁃ 1247 .

TAO Y , XIAO L , HUANG J , et al . The protective effect of Ulinastatin on sepsis through miR⁃21/p38MAPK pathway [J ] . Chin J Emerg Med , 2018 , 27 ( 11 ): 1242 ⁃ 1247 .

孙玮 . 乌司他丁联合床旁高流量持续血液净化治疗重症急性胰腺炎效果观察 [J ] . 山东医药 , 2018 , 58 ( 30 ): 65 ⁃ 67 .

SUN W . Effect of ulinastatin combined with continuous bedside high flow blood purification in the treatment of severe acute pancreatitis [J ] . Shandong Med J , 2018 , 58 ( 30 ): 65 ⁃ 67 .

Views

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

Mechanism of disulfiram in alleviating sepsis‐induced acute lung injury by suppressing pyroptosis in mice

Hemoglobin β⁃subunit attenuates sepsis‐induced acute lung injury by modulating glycolysis in pulmonary vascular endothelium

Inhibiting UBE2O attenuates sepsis⁃induced acute lung injury by upregulating BMAL1 expression

Esketamine alleviates septic lung injury via Keap1/Nrf2⁃HO⁃1 pathway

Research progress on ADAMTS4 in acute lung injury/acute respiratory distress syndrome

Related Author

LI Shoupeng

XIE Xinyu

WU Miao

BAI Jiawei

MA Chengtai

CAI Li

ZHU Ruiyao

YAN Yan

Related Institution

Dept. of Critical Care Medicine, Wuhan Third Hospital & Tongren Hospital of Wuhan University

Department of Critical Care Medicine, Renmin Hospital of Wuhan University

Department of Infection Prevention and Control, Renmin Hospital of Wuhan University

Department of Critical Care Medicine, Renmin Hospital of Wuhan University

Eye Center, Renmin Hospital of Wuhan University

AI问答

⁰